Pelonio, Lorna .

HRN: 27-66-91  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/11/2026
04/11/2026
IV
2g
PTOR
Elective TAHBSO
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: